Free Trial

Abpro (ABP) Competitors

Abpro logo
$0.32 +0.05 (+18.53%)
As of 07/25/2025 04:00 PM Eastern

ABP vs. VTVT, RENB, ALGS, ATNM, PDSB, SNTI, DTIL, NRXP, OSTX, and ZIVO

Should you be buying Abpro stock or one of its competitors? The main competitors of Abpro include vTv Therapeutics (VTVT), Renovaro (RENB), Aligos Therapeutics (ALGS), Actinium Pharmaceuticals (ATNM), PDS Biotechnology (PDSB), Senti Biosciences (SNTI), Precision BioSciences (DTIL), NRx Pharmaceuticals (NRXP), OS Therapies (OSTX), and ZIVO Bioscience (ZIVO). These companies are all part of the "pharmaceutical products" industry.

Abpro vs. Its Competitors

vTv Therapeutics (NASDAQ:VTVT) and Abpro (NASDAQ:ABP) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation.

Abpro has lower revenue, but higher earnings than vTv Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
vTv Therapeutics$1.02M48.26-$18.46M-$3.01-5.13
Abpro$180K106.52-$7.23MN/AN/A

17.5% of vTv Therapeutics shares are owned by institutional investors. Comparatively, 23.3% of Abpro shares are owned by institutional investors. 4.2% of vTv Therapeutics shares are owned by insiders. Comparatively, 20.8% of Abpro shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Abpro's return on equity of 0.00% beat vTv Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
vTv TherapeuticsN/A -121.46% -46.75%
Abpro N/A N/A -198.95%

vTv Therapeutics presently has a consensus price target of $35.50, indicating a potential upside of 130.07%. Abpro has a consensus price target of $4.00, indicating a potential upside of 1,168.23%. Given Abpro's higher probable upside, analysts plainly believe Abpro is more favorable than vTv Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
vTv Therapeutics
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Abpro
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, vTv Therapeutics and vTv Therapeutics both had 1 articles in the media. Abpro's average media sentiment score of 1.87 beat vTv Therapeutics' score of 1.28 indicating that Abpro is being referred to more favorably in the news media.

Company Overall Sentiment
vTv Therapeutics Positive
Abpro Very Positive

Summary

Abpro beats vTv Therapeutics on 7 of the 10 factors compared between the two stocks.

Get Abpro News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ABP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ABP vs. The Competition

MetricAbproMED IndustryMedical SectorNASDAQ Exchange
Market Cap$16.17M$3.07B$5.70B$9.50B
Dividend YieldN/A2.37%4.60%4.01%
P/E RatioN/A21.1828.1020.05
Price / Sales106.52286.99429.3789.38
Price / CashN/A42.7636.2258.56
Price / Book-1.098.378.665.87
Net Income-$7.23M-$55.19M$3.25B$258.55M
7 Day Performance54.68%5.88%4.22%3.73%
1 Month Performance41.43%17.33%10.51%11.75%
1 Year PerformanceN/A4.42%34.40%18.03%

Abpro Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABP
Abpro
N/A$0.32
+18.5%
$4.00
+1,168.2%
N/A$16.17M$180K0.0015Positive News
Gap Up
High Trading Volume
VTVT
vTv Therapeutics
1.54 of 5 stars
$17.03
+1.6%
$35.50
+108.5%
-26.6%$53.57M$1.02M-5.669News Coverage
Positive News
RENB
Renovaro
2.2249 of 5 stars
$0.31
+0.1%
N/A-75.3%$53.01MN/A-0.4020
ALGS
Aligos Therapeutics
4.3029 of 5 stars
$9.12
+5.6%
$70.00
+667.5%
-32.4%$52.83M$3.27M-0.5290News Coverage
Positive News
ATNM
Actinium Pharmaceuticals
2.4484 of 5 stars
$1.82
+7.7%
$4.00
+119.8%
N/A$52.72MN/A-1.3130
PDSB
PDS Biotechnology
1.2528 of 5 stars
$1.15
flat
$9.00
+682.6%
-70.1%$52.57MN/A-1.2220
SNTI
Senti Biosciences
2.2678 of 5 stars
$1.99
+0.5%
$8.50
+327.1%
-16.8%$51.64M$2.56M-0.184
DTIL
Precision BioSciences
4.0884 of 5 stars
$4.86
+4.5%
$47.00
+867.1%
-49.4%$51.56M$51.14M-2.42200Upcoming Earnings
NRXP
NRx Pharmaceuticals
2.5264 of 5 stars
$2.99
+0.3%
$28.50
+853.2%
+28.2%$51.52MN/A-1.492
OSTX
OS Therapies
2.0633 of 5 stars
$1.82
+7.7%
$18.00
+889.0%
N/A$51.14MN/A-2.12N/AGap Up
ZIVO
ZIVO Bioscience
N/A$13.25
flat
N/A+30.2%$50.58M$15.85K-2.7210

Related Companies and Tools


This page (NASDAQ:ABP) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners